Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
78,337,002
-
Share change
-
-11,097,348
-
Total reported value
-
$66,619,526
-
Price per share
-
$0.85
-
Number of holders
-
68
-
Value change
-
-$40,094,718
-
Number of buys
-
36
-
Number of sells
-
82
Institutional Holders of RUBIUS THERAPEUTICS INC - COM (RUBY) as of Q2 2022
As of 30 Jun 2022,
RUBIUS THERAPEUTICS INC - COM (RUBY) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,337,002 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, BAILLIE GIFFORD & CO, Artal Group S.A., Capital World Investors, VANGUARD GROUP INC, BlackRock Inc., Abbot Financial Management, Inc., HarbourVest Partners LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.